Journal of Assisted Reproduction and Genetics

, Volume 33, Issue 9, pp 1161–1168 | Cite as

Molecular cytogenetic characterization of two Turner syndrome patients with mosaic ring X chromosome

  • Pooja Chauhan
  • Sushil Kumar Jaiswal
  • Anjali Rani Lakhotia
  • Amit Kumar RaiEmail author



In the present study, we reported two cases of TS with mosaic ring X chromosome showing common clinical characteristics of TS like growth retardation and ovarian dysfunction. The purpose of the present study was to cytogenetically characterize both cases.


Whole blood culture and G-banding were performed for karyotyping the cases following standard protocol. Origin of the ring chromosome and degree of mosaicism were further determined by fluorescence in situ hybridization (FISH). Breakpoints and loss of genetic material in formation of different ring X chromosomes r (X) in cases were determined with the help of cytogenetic microarray.


Cases 1 and 2 with ring chromosome were cytogenetically characterized as 45, X [114]/46Xr (X) (p22.11q21.32) [116] and 45, X [170]/46, Xr (X) (p22.2q21.33) [92], respectively. Sizes of these ring X chromosomes were found to be ~75 and ~95 Mb in cases 1 and 2, respectively, using visual estimation as part of cytogenetic observation. In both cases, we observed breakpoints on Xq chromosome were within relatively narrow region between Xq21.33 and Xq22.1 compared to regions in previously reported cases associated with ovarian dysgenesis.


Our observation agrees with the fact that despite of large heterogeneity, severity of the cases with intact X-inactive specific transcript (XIST) is dependent on degree of mosaicism and extent of Xq deletion having crucial genes involved directly or indirectly in various physiological involving ovarian cyclicity.


Turner syndrome Ovarian dysfunction Ring X chromosome Fluorescence in situ hybridization (FISH) Cytogenetic microarray 



We thank the parents for giving consent to publish the data. We record words of gratitude to our teacher Professor Rajiva Raman for critical analysis and comments. We are thankful to anonymous reviewers for their suggestions in improving the manuscript. We are thankful to Centre for Genetic Disorders, BHU, for chromosomal analysis and innovative programme of UGC for hormonal assay experiment and Interdisciplinary School of Life Sciences, BHU, Varanasi, for cytogenetic microarrays. Banaras Hindu University, Varanasi, and Indian Council of Medical Research, New Delhi, are highly acknowledged for providing fellowship. This work forms part of the contribution of the Disease biology thrust area under DBT, New Delhi, sponsored by Interdisciplinary School of Life Sciences, BHU.


  1. 1.
    Andreeva P. Thyroid gland and fertility. Akush Ginekol (Sofiia). 2014;53:18–23.Google Scholar
  2. 2.
    Atkins L, Sceery RT, Keenan ME. An unstable ring chromosome in a female infant with hypotonia, seizures, and retarded development. J Med Genet. 1966;3:134.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Baldwin EL, May LF, Justice AN, Martin CL, Led-better DH. Mechanisms and consequences of small supernumerary marker chromosomes: from Barbara McClintock to modern genetic counseling issues. Am J Hum Genet. 2008;82:398–410.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Cho EH, Kim SY, Kim JK. A case of 9.7 Mb terminal Xp deletion including OA1 locus associated with contiguous gene syndrome. J Korean Med Sci. 2012;27:1273–7.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Cho MK. Thyroid dysfunction and subfertility. Clin Exp Reprod Med. 2015;42:131–5.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    de Moraes-Ruehsen M, Jones GS. Premature ovarian failure. Fertil Steril. 1967;18:440–61.CrossRefPubMedGoogle Scholar
  7. 7.
    Dennis N, Coppin B, Turner C, Skuse D, Jacobs P. A clinical, cytogenetic and molecular study of 47 females with r (X) chromosomes. Ann Hum Genet. 2000;64:277–93.CrossRefPubMedGoogle Scholar
  8. 8.
    Eggermann T, Meschede D, Schuler H, Palm S, Glaser D, Horsthemke B, et al. Premature ovarian failure associated with a small terminal Xq deletion: narrowing the POF1 region down to Xq27.2/Xq27.3-qter. Clin Genet. 2005;67(5):434–7.CrossRefPubMedGoogle Scholar
  9. 9.
    Gazdag E, Santenard A, Ziegler-Birling C, Altobelli G, Poch O, Tora L, et al. TBP2 is essential for germ cell development by regulating transcription and chromatin condensation in the oocyte. Genes Dev. 2009;23:2210–23.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Guilherme RS, Klein E, Hamid AB, Bhatt S, Volleth M, Polityko A, et al. Human ring chromosomes—new insights for their clinical significance. BJMG. 2013;16:13–20.PubMedPubMedCentralGoogle Scholar
  11. 11.
    Jacobs P, Dalton P, James R, Mosse K, Power M, Robinson D, et al. Turner syndrome: a cytogenetic and molecular study. Ann Hum Genet. 1997;61:471–83.CrossRefPubMedGoogle Scholar
  12. 12.
    Jaiswal SK, Kumar A, Ali A, Rai AK. Co-occurrence of mosaic supernumerary isochromosome 18p and intermittent 2q13 deletions in a child with multiple congenital anomalies. Gene. 2015;559:94–8.CrossRefPubMedGoogle Scholar
  13. 13.
    James RS, Coppin B, Dalton P, Dennis NR, Mitchell C, Sharp AJ, et al. A study of females with deletions of the short arm of the X chromosome. Hum Genet. 1998;102:507–16.CrossRefPubMedGoogle Scholar
  14. 14.
    Kim MK, Seok HH , Kim YS, Chin MU, Sung SR, Lee WS, et al. Molecular genetic and cytogenetic characterization of a partial Xp duplication and Xq deletion in a patient with premature ovarian failure. Gene. 2014; 534:54–59.Google Scholar
  15. 15.
    Knijnenburg J, van Haeringen A, Hansson KB, Lankester A, Smit MJ, Belfroid RD, et al. Ring chromosome formation as a novel escape mechanism in patients with inverted duplication and terminal deletion. Eur J Hum Genet. 2007;15:548–55.CrossRefPubMedGoogle Scholar
  16. 16.
    Lachlan KL, Youings S, Costa T, Jacobs PA, Thomas NS. A clinical and molecular study of 26 females with Xp deletions with special emphasis on inherited deletions. Hum Genet. 2006;118:640–51.CrossRefPubMedGoogle Scholar
  17. 17.
    Leppig KA, Disteche CM. Ring X and other structural X chromosome abnormalities: X inactivation and phenotype. Semin Reprod Med. 2001;19:147–57.Google Scholar
  18. 18.
    Leppig KA, Sybert VP, Ross JL, Cunniff C, Trejo T, Raskind WH, et al. Phenotype and X inactivation in 45, X/46, X, r (X) cases. Am J Med Genet A. 2004;128:276–84.CrossRefGoogle Scholar
  19. 19.
    Lindgren V, Chen CP, Bryke CR, Lichter P, Page DC, Yang-Feng TL. Cytogenetic and molecular characterization of marker chromosomes in patients with mosaic 45, X karyotypes. Hum Genet. 1992;88:393–8.CrossRefPubMedGoogle Scholar
  20. 20.
    Maraschio P, Tupler R, Barbierato L, Dainotti E, Larizza D, Bernardi F, et al. An analysis of Xq deletions. Hum Genet. 1996;97:375–81.CrossRefPubMedGoogle Scholar
  21. 21.
    Marozzi A, Manfredini A, Tibileth MG, Furlan D, Villa N, Vegetti W, et al. Molecular definition of Xq common-deleted region in patients affected by premature ovarian failure. Hum Genet. 2000;1074:304–11.CrossRefGoogle Scholar
  22. 22.
    Matsuo M, Muroya K, Adachi M, Tachibana K, Asakura Y, Nakagomi Y, et al. Clinical and molecular studies in 15 females with ring X chromosomes: implications for r (X) formation and mental development. Hum Genet. 2000;107:433–9.CrossRefPubMedGoogle Scholar
  23. 23.
    Mercer CL, Lachlan K, Karcanias A, Affara N, Huang S, Jacobs PA, et al. Detailed clinical and molecular study of 20 females with Xq deletions with special reference to menstruation and fertility. Eur J Med Genet. 2013;56:1–6.CrossRefPubMedGoogle Scholar
  24. 24.
    Merhi ZO, Roberts JL, Awonuga AO. A case of 46, X, der (X) t (X;X) (q22.1;p11) Xq22.1> Xqter in a 12 year old girl with premature ovarian failure. Gynecol Obstet Invest. 2007;63:1379.Google Scholar
  25. 25.
    Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res. 1988;16:1215.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Ogata T, Matsuo N. Turner syndrome and female sex chromosome aberrations: deduction of the principal factors involved in the development of clinical features. Hum Genet. 1995;95:607–29.CrossRefPubMedGoogle Scholar
  27. 27.
    Ogata T, Matsuo N, Fukushima Y, Saito M, Nose O, Miharu N, et al. FISH analysis for apparently simple terminal deletions of the X chromosome: identification of hidden structural abnormalities. Am J Med Genet. 2001;104:307–11.CrossRefPubMedGoogle Scholar
  28. 28.
    Pfeiffer RA. Observations in a case of an X/Y translocation, t (X; Y) (p22; q11), in a mother and son. Cytogenet Cell Genet. 1980;26:150–7.CrossRefPubMedGoogle Scholar
  29. 29.
    Powell CM, Taggart RT, Drumheller TC, Wangsa D, Qian C, Nelson LM, et al. Molecular and cytogenetic studies of an X autosome translocation in a patient with premature ovarian failure and review of the literature. Am J Med Genet. 1994;52:19–26.CrossRefPubMedGoogle Scholar
  30. 30.
    Prandstraller D, Mazzanti L, Picchio FM, Magnani C, Bergamaschi R, Perri A, et al. Turner’s syndrome: cardiologic profile according to the different chromosomal patterns and long-term clinical follow-up of 136 nonpreselected patients. Pediatr Cardiol. 1999;20:108–12.CrossRefPubMedGoogle Scholar
  31. 31.
    Rice S, Christoforidis N, Gadd C, Nikolaou D, Seyani L, Donaldson A, et al. Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries. Hum Reprod. 2005;20:373–81.CrossRefPubMedGoogle Scholar
  32. 32.
    Rizzolio F, Bione S, Sala C, Goegan M, Gentile M, Gregato G, et al. Chromosomal rearrangements in Xq and premature ovarian failure: mapping of 25 new cases and review of the literature. Hum Reprod. 2006;21:1477–83.CrossRefPubMedGoogle Scholar
  33. 33.
    Rossetti F, Rizzolio F, Pramparo T, Sala C, Bione S, Bernadi F, et al. A susceptibility gene for premature ovarian failure (POF) maps to proximal Xq28. Eur J Hum Genet. 2004;12:829–34.CrossRefPubMedGoogle Scholar
  34. 34.
    Sala C, Arrigo G, Torri G, Martinazzi F, Riva P, Larizza L, et al. Eleven X chromosome breakpoints associated with premature ovarian failure (POF) map to a 15-Mb Yac contig spanning Xq21. Genomics. 1997;40:123–31.CrossRefPubMedGoogle Scholar
  35. 35.
    Schlessinger D, Herrera L, Crisponi L, Mumm S, Percesepe A, Pellegrini M, et al. Genes and translocations involved in POF. Am J Med Genet. 2002;111:328–33.CrossRefPubMedGoogle Scholar
  36. 36.
    Schuh-Huerta SM, Johnson NA, Rosen MP, Sternfeld B, Cedars MI, Reijo Pera RA. Genetic markers of ovarian follicle number and menopause in women of multiple ethnicities. Hum Genet. 2012;131:1709–24.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Seghezzi L, Maraschio P, Bozzola M, Maserati E, Tupler R, Marchi A, et al. Ring chromosome 9 with a 9p22.3-p24.3 duplication. Eur J Pediat. 1999;158:791–3.CrossRefGoogle Scholar
  38. 38.
    Sigurdardottir S, Goodman BK, Rutberg J, Thomas GH, Jabs EW, Geraghty MT. Clinical, cytogenetic, and fluorescence in situ hybridization findings in two cases of “complete ring” syndrome. Am J Med Genet. 1999;87:384–90.Google Scholar
  39. 39.
    Stochholm K, Juul S, Juel K, Naeraa RW, Gravholt CH. Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J Clin Endocrinol Metab. 2006;91:3897–902.Google Scholar
  40. 40.
    Sybert VP. The adult with Turners syndrome: May 18-21; Gothenburg, Sweden. Edited by: Albertsson-Wikland K, Ranke MB. Amsterdam, Lausanne, New York, Oxford, Shannon, Tokyo: Elsevier 1995.Google Scholar
  41. 41.
    Tharapel AT, Anderson KP, Simpson JL, Martens PR, Wilroy RS, Llerena JC, et al. Deletion (X) (q26.1 –N q28) in a proband and her mother: molecular characterization and phenotypic–karyotypic deductions. Am J Hum Genet. 1993;52:463–71.PubMedPubMedCentralGoogle Scholar
  42. 42.
    Therman E, Laxova R, Susman B. The critical region on the humanXq. Hum Genet. 1990;85:455–61.PubMedGoogle Scholar
  43. 43.
    Tomkins DJ, McDonald HL, Farrell SA, Brown CJ. Lack of expression of XIST from a small ring X chromosome containing the XIST locus in a girl with short stature, facial dysmorphism and developmental delay. Eur J Hum Genet. 2002;10:44–51.CrossRefPubMedGoogle Scholar
  44. 44.
    Toniolo D. X-linked premature ovarian failure: a complex disease. Curr Opin Genet Dev. 2006;16:293–300.CrossRefPubMedGoogle Scholar
  45. 45.
    Van Dyke DL, Wiktor A, Palmer CG, Miller DA, Witt M, Babu VR, et al. Ullrich-Turner syndrome with a small ring X chromosome and presence of mental retardation. Am J Med Genet. 1992;43:996–1005.CrossRefPubMedGoogle Scholar
  46. 46.
    Wei Y, Reveal B, Reich J, Laursen WJ, Senger S, Akbar T, et al. TORC1 regulators Iml1/GATOR1 and GATOR2 control meiotic entry and oocyte development in Drosophila. Proc Natl Acad Sci U S A. 2014;111:5670–7.CrossRefGoogle Scholar
  47. 47.
    Wyss D, DeLozier CD, Daniell J, Engel E. Structural anomalies of the X chromosome: personal observation and review of non-mosaic cases. Clin Genet. 1982;21:145–59.CrossRefPubMedGoogle Scholar
  48. 48.
    Zinn AR, Ross JL. Molecular analysis of genes on Xp controlling Turner syndrome and premature ovarian failure (POF). Semin Reprod Med. 2001;19:141–6.CrossRefPubMedGoogle Scholar
  49. 49.
    Zinn AR, Tonk VS, Chen Z, Flejter WL, Gardner HA, Guerra R, et al. Evidence for a Turner syndrome locus or loci at Xp11.2–p22.1. Am J Hum Genet. 1998;63:1757–66.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Pooja Chauhan
    • 1
  • Sushil Kumar Jaiswal
    • 1
  • Anjali Rani Lakhotia
    • 2
  • Amit Kumar Rai
    • 1
    Email author
  1. 1.Centre for Genetic Disorders, Institute of ScienceBanaras Hindu UniversityVaranasiIndia
  2. 2.Institute of Medical SciencesBanaras Hindu UniversityVaranasiIndia

Personalised recommendations